Company Overview

Update
Founded:
1994
Closed:
Closed, Date Unknown
Headquarters:
Laval
Funding:
$1.4M
Categories:
Biotechnology
Description:
Biosyntech is engaged in the development of biotherapeutic thermogels for tissue repair and the delivery of therapeutic agents.

Detailed Description

Update

BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. Its technology platform is BST-Gel, a family of hydrogels based on chitosan, a natural biopolymer derived from crustacean shells. The company’s lead products in clinical trials include BSTCarGel for cartilage repair; BST-DermOn for wound healing; and BST-InPod for the treatment of chronic pain due to plantar fat pad atrophy in the heel and forefoot.

Biosyntech has a collaboration with Nicholas Piramal India, Ltd. to involve in the clinical studies for BST-InPod, which is being developed to alleviate the chronic pain associated with foot fat pads. The company was incorporated in 1994 and is headquartered in Laval, Canada.

Investors (4)

Update

Offices/Locations (1)

Update
  • HQ

    475 Armand-Frappier Blvd.

    Laval, H7V 4B3

    CAN

Images (1)

Update
  • 68c813bdd0f8bed2441c984f879d2279